The USP of the CANTREAT-Method

“Drug targeting” means the targeted administration of pharmaceuticals, is being investigated by many research institutions worldwide. Scientists are pursuing a wide variety of approaches that should make it possible to offer a more efficient and gentle therapy with as few side effects as possible. Partial successes have been achieved, but the major breakthrough is still missing. In many cases, the financial and technical outlay is relatively high, which is why research has often come to a standstill.

CANTREAT combines previous positive research approaches and leads them via further development steps and new materials and innovative techniques, which are unique worldwide, to a comprehensively efficient result. In addition to the desired effect of being able to apply the therapeutic agent in a targeted manner and in as small a dose as possible in the area of application, costly and massive apparatus can be dispensed with. In addition, the organism is not additionally impaired by tissue-damaging effects during a CANTREAT therapy.

The CANTREAT System, with its patent-pending components, represents a medical novelty in this field and can rightly be called a revolution.